Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Patients with acquired Gerbode defect undergoing previous cardiac surgery

From: Acquired Gerbode defect following endocarditis of the tricuspid valve: a case report and literature review

Author Year Gender Age Diagnostic tool Previous procedure Treatment Outcome
1. Katta et al. 1994 Male 54 TTE,TEE Endomyocardial biopsy Conservative Survived
2. Dzwonczyk et al. 1995 Male 25 TTE ASD repair na na
3. Dzwonczyk et al. 1995 Female 72 TTE AVR, VSD repair na na
4. Fukui et al. 2000 Male 53 TEE MVR x 2 Surgery Survived
5. Benisty et al. 2000 Male 72 TTE, TEE MVR Surgery n.a.
6. Benisty et al. 2000 Male 73 TTE, TEE MVR x 3, AVR Surgery n.a.
7. Weinrich et al. 2001 Female 58 TEE, CC MVRx 2 Surgery Survived
8. Wasserman et al. 2002 Male 78 TTE, TEE, AVR Surgery Survived
9. Cabalka et al. 2005 Female 70 TTE, TEE MVR x 2 Percutaneous Survived
10. Lorber et al. 2006 Female 78 TTE, CC MVR Percutaneous Survived
11. Ramasubbu et al. 2006 Male 41 TEE Aortic root reconstruction Surgery Survived
12. Ramasubbu et al. 2006 Female 44 TEE Aortic root reconstruction Conservative Survived
13. Trehan et al. 2006 Male 22 TTE, MRI, CC VSD + sinus valsalva repair Percutaneous Survived
14. Martinez et al. 2007 Female 70 TTE MVR Percutaneous Survived
15. Martinez et al. 2007 Male 67 TTE AVR Percutaneous Survived
16. Uslu et al. 2007 Male 54 TTE MVR Surgery Survived
17. Hilberath et al. 2007 Male 68 TEE AVR + endocarditis Surgery Survived
18. Frigg et al. 2008 Female 77 TEE, CC AVR Surgery Survived
19. Moaref et al. 2008 Female 51 TEE MVR Surgery na
20. Aoyagi et al. 2008 Female 71 TTE, CC MVR, TV repair Surgery Survived
21. Rothman et al. 2008 Male 86 TTE, CC MVR Percutaneous Survived
22. Hansalia et al. 2009 Female 46 TTE AVR Surgery Survived
23. Yared et al. 2009 Male 60 TTE, TTE AVR+ endocarditis na na
24. Gorki et al. 2009 Female 69 na AVR + endocarditis na na
25. Subramaniam et al. 2009 Male 60 TEE, CT AVR Surgery Survived
26. Amirghofran et al. 2009 Female 51 TEE MVR Surgery Survived
27. Silbiger et al. 2009 Female 30 TTE, CC VSD repair Conservative Survived
28. Cheema et al. 2009 Female 31 MRI VSD repair Conservative Survived
29. Can et al. 2009 Male 72 TTE AV nod ablation Conservative Survived
30. Can et al. 2009 Male 68 Autopsy AV nod ablation na Died
31. Dadkhah et al. 2009 Female 73 TEE TV repair Conservative Survived
32. Mohapatra et al 2009 Female 22 TEE MVR (RF) Surgery Survived
33. Sun et al. 2010 na na na MVR Surgery na
34. Sun et al. 2010 na na na MVR na na
35. Pursnani et al. 2010 Male 78 TTE, TEE AVR Surgery Survived
36. Sharma et al. 2011 Male 80 TTE AV nod ablation Conservative Survived
37. Kumar et al. 2011 Female 59 TEE AVRx2 + endocarditis Surgery Survived
38. Zhu et al. 2012 Baby 6 months TTE, TEE ASD, VSD repair Percutaneous Survived
39. Bochard-Villanueva 2012 Male 63 TEE, CT AVR+ endocarditis Surgery Survived
40. Vallakati et al. 2012 Female 53 TTE AVR Conservative Survived
41. Elmistekawy et al. 2012 Male 59 TEE AVR Surgery Survived
42. Dores et al. 2012 Male 50 TTE, TEE AVR, MVR Surgery Survived
43. Yurdakul et al. 2012 Male 68 TEE AVR Surgery Survived
44. Mousavi et al. 2012 Female 76 TEE, MRI AVR Conservative Survived
45. Ozdogan et al. 2012 Female 31 TTE, TEE MVRx2 + endocarditis Surgery Died
46. Anderson et al. 2012 na na na AVR na na
47. Toprak et al. 2013 Male 32 TTE, TEE AVR Conservative Survived
48. Notarangelo et al. 2013 n.a. 69 TTE, TEE MVR Percutaneous Survived
49. Sinisalo et al. 2013 Male 75 TTE, TEE, CC AVR Percutaneous Survived
50. Sinisalo et al. 2013 Female 23 TEE, CC VSD repair Percutaneous Survived
51. Sinisalo et al. 2013 Male 10 TEE, CC ASD, VSD repair Percutaneous Survived
52. Sinisalo et al. 2013 Male 8 TEE, CC VSD repair Percutaneous Survived
53. Dangol et al. 2013 Male 6 months TTE,TEE,CC ToF repair Percutaneous Survived
54. Lee et al. 2013 Male 3 months TTE, CC ASD, PDA, VSD repair Percutaneous Survived
55. Poulin et al. 2013 Female 75 TTE,TEE MVR Percutaneous Survived
56. Primus et al. 2013 Female 76 TTE,TEE AVR Conservative Survived
57. Chaturvedi et al. 2013 Male 62 TTE, MRI AVR Percutaneous Survived
58. Tayama et al. 2014 Male 75 TTE, CC MV and TV repair Surgery Survived
59. Hussain et al. 2014 Male 45 TTE, TEE AVRx2 Surgery Survived
60. Chamsi-Pasha et al 2014 Male 67 TTE, TEE MVR, TVR Surgery Survived
61. Taskesen et al. 2014 Male 74 TTE, TEE AVRx2 Percutaneous Survived
62. Fanari et al 2015 Female 50 TTE, CT AVR Percutaneous Survived
  1. Patients with acquired Gerbode defect undergoing previous cardiac surgery
  2. Legend: TTE Transthoracic echocardiography, TEE Transesophageal echocardiography, CC Cardiac catheterization, CT Cardiac tomography, MRI Magnetic resonance, na-not available, AVR Aortic valve replacement, MVR Mitral valve replacement, TV Tricuspid valve, ASD Atrial septal defect, VSD Ventricular septal defect, ToF Tetralogy of Fallot, PDA Patent ductus arteriosum